Impact of SBI, a Medical Food, on Nutritional Status in Patients With HIV-associated Enteropathy

Completed · Not applicable · Has a placebo group

Conditions studied: HIV-associated Enteropathy

In brief

The purpose of the study is to evaluate the effectiveness of the oral nutritional therapy serum-derived bovine immunoglobulin protein isolate (SBI) 2.5 g twice a day (BID) and SBI 5.0 g versus placebo on supporting nutrient absorption in HIV+ subjects with HIV-associated enteropathy.

Key facts

Study ID
NCT01828593
Run by
Entera Health, Inc
People needed
103
Starts
2013-04-01
Expected to finish
2014-09-01
Last updated by the study team
2017-06-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.